Nuclear factor of activated T cells-dependent downregulation of the transcription factor glioma-associated protein 1 (GLI1) underlies the growth inhibitory properties of arachidonic acid

Andrea Comba, Luciana L. Almada, Ezequiel J. Tolosa, Eriko Iguchi, David L. Marks, Marianela Vara Messler, Renata Silva, Maite G. Fernandez-Barrena, Elisa Enriquez-Hesles, Anne L. Vrabel, Bruno Botta, Lucia Di Marcotulio, Volker Ellenrieder, Aldo R. Eynard, Maria E. Pasqualini, Martin E Fernandez-Zapico

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Numerous reports have demonstrated a tumor inhibitory effect of polyunsaturated fatty acids (PUFAs). However, the molecular mechanisms modulating this phenomenon are in part poorly understood. Here, we provide evidence of a novel antitumoral mechanism of the PUFA arachidonic acid (AA). In vivo and in vitro experiments showed that AA treatment decreased tumor growth and metastasis and increased apoptosis. Molecular analysis of this effect showed significantly reduced expression of a subset of antiapoptotic proteins, including BCL2, BFL1/A1, and 4-1BB, in AA-treated cells.Wedemonstrated that down-regulation of the transcription factor gliomaassociated protein 1 (GLI1) in AA-treated cells is the underlying mechanism controlling BCL2, BFL1/A1, and 4-1BB expression. Using luciferase reporters, chromatin immunoprecipitation, and expression studies, we found that GLI1 binds to the promoter of these antiapoptotic molecules and regulates their expression and promoter activity. We provide evidence that AA-induced apoptosis and down-regulation of antiapoptotic genes can be inhibited by overexpressing GLI1 in AA-sensitive cells. Conversely, inhibition of GLI1 mimics AA treatments, leading to decreased tumor growth, cell viability, and expression of antiapoptotic molecules. Further characterization showed thatAArepresses GLI1 expression by stimulating nuclear translocation of NFATc1, which then binds the GLI1 promoter and represses its transcription. AA was shown to increase reactive oxygen species. Treatment with antioxidants impaired the AAinduced apoptosis and down-regulation of GLI1 and NFATc1 activation, indicating that NFATc1 activation and GLI1 repression require the generation of reactive oxygen species. Collectively, these results define a novel mechanism underlying AA antitumoral functions that may serve as a foundation for future PUFA-based therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)1933-1947
Number of pages15
JournalJournal of Biological Chemistry
Volume291
Issue number4
DOIs
StatePublished - Jan 22 2016

Fingerprint

NFATC Transcription Factors
Arachidonic Acid
Glioma
Transcription Factors
Down-Regulation
Growth
Proteins
Unsaturated Fatty Acids
Tumors
Apoptosis
Proto-Oncogene Proteins c-bcl-2
Reactive Oxygen Species
Chemical activation
Cells
Neoplasms
Molecules
Chromatin Immunoprecipitation
Cell growth
Transcription
Luciferases

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Nuclear factor of activated T cells-dependent downregulation of the transcription factor glioma-associated protein 1 (GLI1) underlies the growth inhibitory properties of arachidonic acid. / Comba, Andrea; Almada, Luciana L.; Tolosa, Ezequiel J.; Iguchi, Eriko; Marks, David L.; Messler, Marianela Vara; Silva, Renata; Fernandez-Barrena, Maite G.; Enriquez-Hesles, Elisa; Vrabel, Anne L.; Botta, Bruno; Di Marcotulio, Lucia; Ellenrieder, Volker; Eynard, Aldo R.; Pasqualini, Maria E.; Fernandez-Zapico, Martin E.

In: Journal of Biological Chemistry, Vol. 291, No. 4, 22.01.2016, p. 1933-1947.

Research output: Contribution to journalArticle

Comba, A, Almada, LL, Tolosa, EJ, Iguchi, E, Marks, DL, Messler, MV, Silva, R, Fernandez-Barrena, MG, Enriquez-Hesles, E, Vrabel, AL, Botta, B, Di Marcotulio, L, Ellenrieder, V, Eynard, AR, Pasqualini, ME & Fernandez-Zapico, ME 2016, 'Nuclear factor of activated T cells-dependent downregulation of the transcription factor glioma-associated protein 1 (GLI1) underlies the growth inhibitory properties of arachidonic acid', Journal of Biological Chemistry, vol. 291, no. 4, pp. 1933-1947. https://doi.org/10.1074/jbc.M115.691972
Comba, Andrea ; Almada, Luciana L. ; Tolosa, Ezequiel J. ; Iguchi, Eriko ; Marks, David L. ; Messler, Marianela Vara ; Silva, Renata ; Fernandez-Barrena, Maite G. ; Enriquez-Hesles, Elisa ; Vrabel, Anne L. ; Botta, Bruno ; Di Marcotulio, Lucia ; Ellenrieder, Volker ; Eynard, Aldo R. ; Pasqualini, Maria E. ; Fernandez-Zapico, Martin E. / Nuclear factor of activated T cells-dependent downregulation of the transcription factor glioma-associated protein 1 (GLI1) underlies the growth inhibitory properties of arachidonic acid. In: Journal of Biological Chemistry. 2016 ; Vol. 291, No. 4. pp. 1933-1947.
@article{1eac096c04d2415098090ae38a578371,
title = "Nuclear factor of activated T cells-dependent downregulation of the transcription factor glioma-associated protein 1 (GLI1) underlies the growth inhibitory properties of arachidonic acid",
abstract = "Numerous reports have demonstrated a tumor inhibitory effect of polyunsaturated fatty acids (PUFAs). However, the molecular mechanisms modulating this phenomenon are in part poorly understood. Here, we provide evidence of a novel antitumoral mechanism of the PUFA arachidonic acid (AA). In vivo and in vitro experiments showed that AA treatment decreased tumor growth and metastasis and increased apoptosis. Molecular analysis of this effect showed significantly reduced expression of a subset of antiapoptotic proteins, including BCL2, BFL1/A1, and 4-1BB, in AA-treated cells.Wedemonstrated that down-regulation of the transcription factor gliomaassociated protein 1 (GLI1) in AA-treated cells is the underlying mechanism controlling BCL2, BFL1/A1, and 4-1BB expression. Using luciferase reporters, chromatin immunoprecipitation, and expression studies, we found that GLI1 binds to the promoter of these antiapoptotic molecules and regulates their expression and promoter activity. We provide evidence that AA-induced apoptosis and down-regulation of antiapoptotic genes can be inhibited by overexpressing GLI1 in AA-sensitive cells. Conversely, inhibition of GLI1 mimics AA treatments, leading to decreased tumor growth, cell viability, and expression of antiapoptotic molecules. Further characterization showed thatAArepresses GLI1 expression by stimulating nuclear translocation of NFATc1, which then binds the GLI1 promoter and represses its transcription. AA was shown to increase reactive oxygen species. Treatment with antioxidants impaired the AAinduced apoptosis and down-regulation of GLI1 and NFATc1 activation, indicating that NFATc1 activation and GLI1 repression require the generation of reactive oxygen species. Collectively, these results define a novel mechanism underlying AA antitumoral functions that may serve as a foundation for future PUFA-based therapeutic approaches.",
author = "Andrea Comba and Almada, {Luciana L.} and Tolosa, {Ezequiel J.} and Eriko Iguchi and Marks, {David L.} and Messler, {Marianela Vara} and Renata Silva and Fernandez-Barrena, {Maite G.} and Elisa Enriquez-Hesles and Vrabel, {Anne L.} and Bruno Botta and {Di Marcotulio}, Lucia and Volker Ellenrieder and Eynard, {Aldo R.} and Pasqualini, {Maria E.} and Fernandez-Zapico, {Martin E}",
year = "2016",
month = "1",
day = "22",
doi = "10.1074/jbc.M115.691972",
language = "English (US)",
volume = "291",
pages = "1933--1947",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Nuclear factor of activated T cells-dependent downregulation of the transcription factor glioma-associated protein 1 (GLI1) underlies the growth inhibitory properties of arachidonic acid

AU - Comba, Andrea

AU - Almada, Luciana L.

AU - Tolosa, Ezequiel J.

AU - Iguchi, Eriko

AU - Marks, David L.

AU - Messler, Marianela Vara

AU - Silva, Renata

AU - Fernandez-Barrena, Maite G.

AU - Enriquez-Hesles, Elisa

AU - Vrabel, Anne L.

AU - Botta, Bruno

AU - Di Marcotulio, Lucia

AU - Ellenrieder, Volker

AU - Eynard, Aldo R.

AU - Pasqualini, Maria E.

AU - Fernandez-Zapico, Martin E

PY - 2016/1/22

Y1 - 2016/1/22

N2 - Numerous reports have demonstrated a tumor inhibitory effect of polyunsaturated fatty acids (PUFAs). However, the molecular mechanisms modulating this phenomenon are in part poorly understood. Here, we provide evidence of a novel antitumoral mechanism of the PUFA arachidonic acid (AA). In vivo and in vitro experiments showed that AA treatment decreased tumor growth and metastasis and increased apoptosis. Molecular analysis of this effect showed significantly reduced expression of a subset of antiapoptotic proteins, including BCL2, BFL1/A1, and 4-1BB, in AA-treated cells.Wedemonstrated that down-regulation of the transcription factor gliomaassociated protein 1 (GLI1) in AA-treated cells is the underlying mechanism controlling BCL2, BFL1/A1, and 4-1BB expression. Using luciferase reporters, chromatin immunoprecipitation, and expression studies, we found that GLI1 binds to the promoter of these antiapoptotic molecules and regulates their expression and promoter activity. We provide evidence that AA-induced apoptosis and down-regulation of antiapoptotic genes can be inhibited by overexpressing GLI1 in AA-sensitive cells. Conversely, inhibition of GLI1 mimics AA treatments, leading to decreased tumor growth, cell viability, and expression of antiapoptotic molecules. Further characterization showed thatAArepresses GLI1 expression by stimulating nuclear translocation of NFATc1, which then binds the GLI1 promoter and represses its transcription. AA was shown to increase reactive oxygen species. Treatment with antioxidants impaired the AAinduced apoptosis and down-regulation of GLI1 and NFATc1 activation, indicating that NFATc1 activation and GLI1 repression require the generation of reactive oxygen species. Collectively, these results define a novel mechanism underlying AA antitumoral functions that may serve as a foundation for future PUFA-based therapeutic approaches.

AB - Numerous reports have demonstrated a tumor inhibitory effect of polyunsaturated fatty acids (PUFAs). However, the molecular mechanisms modulating this phenomenon are in part poorly understood. Here, we provide evidence of a novel antitumoral mechanism of the PUFA arachidonic acid (AA). In vivo and in vitro experiments showed that AA treatment decreased tumor growth and metastasis and increased apoptosis. Molecular analysis of this effect showed significantly reduced expression of a subset of antiapoptotic proteins, including BCL2, BFL1/A1, and 4-1BB, in AA-treated cells.Wedemonstrated that down-regulation of the transcription factor gliomaassociated protein 1 (GLI1) in AA-treated cells is the underlying mechanism controlling BCL2, BFL1/A1, and 4-1BB expression. Using luciferase reporters, chromatin immunoprecipitation, and expression studies, we found that GLI1 binds to the promoter of these antiapoptotic molecules and regulates their expression and promoter activity. We provide evidence that AA-induced apoptosis and down-regulation of antiapoptotic genes can be inhibited by overexpressing GLI1 in AA-sensitive cells. Conversely, inhibition of GLI1 mimics AA treatments, leading to decreased tumor growth, cell viability, and expression of antiapoptotic molecules. Further characterization showed thatAArepresses GLI1 expression by stimulating nuclear translocation of NFATc1, which then binds the GLI1 promoter and represses its transcription. AA was shown to increase reactive oxygen species. Treatment with antioxidants impaired the AAinduced apoptosis and down-regulation of GLI1 and NFATc1 activation, indicating that NFATc1 activation and GLI1 repression require the generation of reactive oxygen species. Collectively, these results define a novel mechanism underlying AA antitumoral functions that may serve as a foundation for future PUFA-based therapeutic approaches.

UR - http://www.scopus.com/inward/record.url?scp=84959020431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959020431&partnerID=8YFLogxK

U2 - 10.1074/jbc.M115.691972

DO - 10.1074/jbc.M115.691972

M3 - Article

C2 - 26601952

AN - SCOPUS:84959020431

VL - 291

SP - 1933

EP - 1947

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -